Skip to main content

Table 1 Clinical characteristics of study population

From: Placental 13C-DHA metabolism and relationship with maternal BMI, glycemia and birthweight

Clinical characteristics

Total (n = 17)

Non-GDM (n = 8)

GDM (n = 9)

Maternal age (years)

33.4 (2.9)

32.5 (2.6)

34.1 (3.2)

Chinese: Indian ethnicity

11 (65%): 6 (35%)

6 (75%): 2 (25%)

5 (56%): 4 (44%)

Maternal BMI in first trimester (kg/m2)

25.4 (4.6)

24.1 (3.9)

26.6 (5)

Normal weight: Overweight: Obesea

5 (29%): 6 (35%): 6 (35%)

3 (38%): 2 (25%): 3 (38%)

2 (22%): 4 (44%): 3 (33%)

Fasting glycemia (mmol/L)b

4.5 (0.5)

4.4 (0.2)

4.6 (0.6)

1-h glycemia (mmol/L)b

9.0 (1.7)

7.8 (1.4)

10.1 (1.15)

2-h glycemia (mmol/L)b

7.6 (1.6)

6.4 (0.9)

8.8 (1.2)

Antenatal PUFA-containing supplementation

6 (35%)

3 (33%)

3 (38%)

Gestational age at delivery (days)

271.4 (5.9)

273.3 (7.4)

269.7 (3.7)

Female neonates

9 (52%)

4 (50%)

5 (56%)

Birthweight (g)

3276.0 (323)

3298.1 (326)

3255.6 (339)

Birthweight centile (%)c

61 (30)

59 (31)

66 (31)

  1. Data presented as Mean (SD) or n (%)
  2. aWHO recommended Asian-specific BMI cut-off that is associated with increased metabolic risk (WHO EC 2004): Normal 18.5–22.9 kg/m2, Overweight 23–27.4 kg/m2, Obese ≥ 27.5 kg/m2
  3. bIn mid-gestation 75 g three time-point OGTT
  4. cBy local sex and gestational age-standardized references